Hamps Bio Limited
Fixed Price IPO · BSE
- Price band
- ₹51 - ₹51
- Lot size
- 2,000 shares
- Issue amount
- ₹6.22 cr
- Total subscription
- 1,050.21×
- Opens
- 13 Dec 2024
- Closes
- 17 Dec 2024
- Allotment
- 18 Dec 2024
- Listing
- 20 Dec 2024
Offer at a glance
Issue overview
- Issue size
- 12,20,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,02,000
- Fresh issue
- ₹6.22 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,02,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 31,36,000
- Shares after issue
- 43,56,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 4,000 | ₹2,04,000 |
| HNI | 3 | 6,000 | ₹3,06,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| RETAIL | 2.96 | 35.92 |
| NIB | 2.95 | 3.73 |
Financial performance
Company financials
In Lakhs. · Reported periods may include interim results.
Key performance indicators
| Metric | Oct-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 1.09 | 1.76 | 1.5 |
| ROE | 16.65 | 21.14 | 30.31 |
| ROCE | 18.53 | 18.31 | 17.43 |
| RONW | 9.19 | 14.84 | 26.34 |
| Pre IPO | 0 | 31.94 | 0 |
| Post IPO | 0 | 38.03 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.
Strengths
- Expert Leadership and Industry Experience: A seasoned and knowledgeable management team drives strategic growth, operational efficiency, and long-term business vision.
- Expansive Distribution Network with E-Retailing: Strong presence across 50+ distributors combined with availability on major e-commerce platforms such as Amazon and Flipkart ensures wide market reach and accessibility.
- Diverse Product Portfolio: With over 180 products spanning pharmaceuticals and FMCG categories, the company caters to a broad customer base across both domestic and international markets.
Risk factors
- Outstanding Litigation: Pending legal disputes may pose financial liabilities and harm the company’s reputation and business operations if outcomes are not favorable.
- Dependence on Third-Party Manufacturing: Heavy reliance on external manufacturers for pharmaceutical products exposes the company to potential supply chain disruptions, quality issues, and compliance risks.
- Single-Region Manufacturing Facility: Concentrating freeze-dried and frozen product manufacturing in Ankleshwar, Gujarat increases vulnerability to regional disruptions, which could adversely impact production and overall business continuity.
Promoters
Herrik Shah
Shrenik Shah
Pallavi Shah
Mitali Shah
Herrik Shah HUF
Shrenik Shah HUF
Registrar & documents
Lead manager
Marwadi Chandarana Intermediaries Brokers Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
2900/112, GIDC, Near Atul Limited, Ankleshwar, Bharuch 393 002
+91 8000006663
[email protected]Company website ↗Frequently Asked Questions
What is Hamps Bio IPO GMP today?
As of today, Hamps Bio IPO Grey Market Premium (GMP) is reported at +₹60 per share. Based on the upper price band of ₹51, the estimated listing price is ₹111 (+117.6% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Hamps Bio IPO?
The minimum bid lot size for Hamps Bio IPO is 2,000 shares. At the cut-off price of ₹51 per share, retail investors need a minimum application amount of ₹1,02,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Hamps Bio IPO allotment status be announced?
The allotment status for Hamps Bio IPO is scheduled to be finalized on 18 Dec 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Hamps Bio IPO allotment status online by PAN?
To check Hamps Bio IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Hamps Bio Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.